Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET Meeting Abstract


Authors: Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; Straus, D. J.; Graustein, T. A.; Teruya-Feldstein, J.; Zelenetz, A. D.
Abstract Title: Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
Meeting Title: 11th International Conference on Malignant Lymphoma
Journal Title: Annals of Oncology
Volume: 22
Issue: Suppl. 4
Meeting Dates: 2011 Jun 15-18
Meeting Location: Lugano, Switzerland
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2011-06-01
Start Page: iv158
Language: English
ACCESSION: WOS:000291996300234
PROVIDER: wos
DOI: 10.1093/annonc/mdr217
PUBMED: 21714157
Notes: Meeting Abstract: 220 -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    206 Portlock
  2. Craig Moskowitz
    407 Moskowitz
  3. Ariela Noy
    373 Noy
  4. Maria Lia Palomba
    446 Palomba
  5. Julie T Feldstein
    298 Feldstein
  6. Steven M Horwitz
    668 Horwitz
  7. Heiko Schoder
    552 Schoder
  8. Andrew D Zelenetz
    784 Zelenetz
  9. Alison Moskowitz
    359 Moskowitz
  10. Paul Hamlin
    293 Hamlin
  11. Matthew J Matasar
    293 Matasar
  12. David J Straus
    361 Straus
Related MSK Work